H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsFeb 28 07:35 ET

BofA Securities Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $12

Moomoo NewsFeb 28 07:35 ET

BTIG Initiates Novavax(NVAX.US) With Buy Rating, Announces Target Price $19

Moomoo NewsFeb 27 19:31 ET

Analysts Offer Insights on Healthcare Companies: Novavax (NVAX) and Ramsay Health Care (OtherRMSYF)

TipRanksFeb 27 18:42 ET

Novavax Initiated With a Buy at BTIG

TipRanksFeb 27 18:32 ET

Novavax: Promising Innovations Amidst Execution and Competitive Challenges – Hold Rating

TipRanksFeb 24 17:31 ET

TD Cowen Initiates Novavax(NVAX.US) With Hold Rating, Announces Target Price $9

Moomoo NewsFeb 24 17:31 ET

BofA Securities Maintains Novavax(NVAX.US) With Hold Rating, Maintains Target Price $12

Moomoo NewsFeb 11 07:31 ET

Bank of America Securities Sticks to Its Hold Rating for Novavax (NVAX)

TipRanksFeb 11 06:50 ET

B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsDec 20, 2024 13:37 ET

Novavax's Strategic Partnerships and Pipeline Developments Drive Buy Rating With Promising Long-term Growth Potential

TipRanksDec 20, 2024 12:59 ET

Novavax Analyst Ratings

BenzingaDec 10, 2024 12:14 ET

H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19

Moomoo NewsDec 10, 2024 10:31 ET

B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsDec 6, 2024 08:31 ET

B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $22

Moomoo NewsNov 19, 2024 03:42 ET

B. Riley Adjusts Novavax Price Target to $22 From $26, Maintains Buy Rating

MT NewswiresNov 18, 2024 09:02 ET

Strategic Transformation and Growth Prospects: Mayank Mamtani's Buy Rating on Novavax

TipRanksNov 18, 2024 08:25 ET

Novavax Analyst Ratings

BenzingaNov 13, 2024 07:39 ET

J.P. Morgan Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $9

Moomoo NewsNov 13, 2024 06:36 ET

Novavax's Market Share and Pipeline Uncertainties Lead to Sell Rating

TipRanksNov 13, 2024 06:22 ET